Apogent to launch $250 million 10-year deal on Wednesday

By Paul A. Harris

St. Louis, May 13 - Apogent Technologies Inc. starts the roadshow Wednesday for $250 million of senior subordinated notes due 2013 (Ba2/BB+), according to an informed source.

The deal is expected to price during the week of May 19, the source added.

Lehman Brothers, Credit Suisse First Boston and JP Morgan are the bookrunners for the Rule 144A deal.

The notes are non-callable for five years.

Proceeds will be used to help repurchase up to 15 million shares.

The company is a Portsmouth, N.H. manufacturer of clinical diagnostic and life science research products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.